(C6)-CP 47,497

File:(C6)-CP 47,497 Structure.svg

(C6)-CP_47,497_Structure.svg

(C6)-CP 47,497 is a synthetic cannabinoid that is structurally related to CP 47,497. It is a member of the class of compounds known as cannabinoids, which interact with the endocannabinoid system in the body. This compound is of interest in the field of pharmacology and neuroscience due to its potential effects on the central nervous system.

Chemical Structure

(C6)-CP 47,497 is a derivative of CP 47,497, where the pentyl side chain is replaced with a hexyl side chain. The chemical structure of (C6)-CP 47,497 includes a cyclohexylphenol core, which is a common feature among synthetic cannabinoids. The modification in the side chain length can influence the compound's binding affinity to cannabinoid receptors.

Pharmacology

(C6)-CP 47,497 acts as an agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the G protein-coupled receptor family and are primarily found in the brain and immune system, respectively. Activation of these receptors by (C6)-CP 47,497 can lead to various physiological and psychoactive effects.

Legal Status

The legal status of (C6)-CP 47,497 varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important to consult local regulations to determine the legality of this compound.

Research and Applications

Research on (C6)-CP 47,497 is ongoing to understand its potential therapeutic applications and risks. Studies have explored its effects on pain management, appetite stimulation, and neuroprotection. However, due to its synthetic nature and potential for adverse effects, it is primarily used in a research context rather than clinical practice.

See Also

• Synthetic cannabinoids
• Endocannabinoid system
• CP 47,497
• Cannabinoid receptor